Abstract:SESSION TITLE: Tuesday Abstract Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: 10/22/2019 01:00 PM - 02:00 PM PURPOSE: The aim of the study is to determine the association of impact factors and predictive biomarkers with high VTE risk in hospitalized patients with AECOPD and to provide the theoretical proof for the early prevention of VTE with low molecular weight heparin (LMWH) based on the prethrombotic state (PTS) of the cohort. METHODS: Hospitalized patients with AECOPD were enrolled prospectively from April 2018 to April 2019. Demographic data including gender, age, smoking history, chronic diseases, arterial blood gas and other clinical data were recorded. These patients were divided into the low-risk group and high-risk group using Padua risk assessment score (PRAS). The high-risk group was further subdivided into anticoagulation group and non-anticoagulation group depending on the use of low molecular weight heparin (LMWH). The plasma levels of new coagulation-fibrinolytic biomarkers such as thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasminogen-α2 plasminogen inhibitor complex (PIC) and tissue-type plasminogen activator-plasminogen activator inhibitor complex (t-PAI-C) as well as routine coagulation-fibrinolysis parameters were measured on admission (D0), the third day (D3) and seventh day (D7) after admission respectively. Same serum samples were also collected and measured in healthy individuals from the physical examination center as a control group. The levels of coagulative parameters and other clinical indices were measured and compared among the groups.The receiver-operating characteristic (ROC) curves of these indices were generated, and the area under the curve (AUC) was calculated. The predictive values of the selected potential parameters were examined in binary regression analysis. RESULTS: A total of 100 patients with AECOPD (48 cases in the low-risk group and 52 cases in the high-risk group) and 20 controls were enrolled in our study. Non-invasive ventilation treatment, deep vein puncture/catheterization, bed rest/immobilized > 3 days, pulmonary heart disease, type-II respiratory failure were more common in the high-risk group. The duration of hospitalization in the high-risk group was significantly longer than that in the low-risk group (P< 0.05). The levels of white blood cell (WBC), neutrophil (NEU), TM, TAT, PIC, t-PAI-C, plasma prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen concentration (FIB), D-Dimer (DD), and fibrinogen degradation product (FDP) on D0 were higher in patients with AECOPD than the cohort in control group (p<0.05). CONCLUSIONS: Non-invasive ventilation treatment, deep vein puncture/catheterization, bed rest/immobilization > 3 days, pulmonary & heart disease, type-II respiratory failure and duration of hospitalization are considered to be associated with higher risk of VTE. The levels of PaCO2, NEU, and TT may serve as predictors for higher risk of VTE and could guide treatment strategies with LMWH to prevent VTE in these patients. CLINICAL IMPLICATIONS: The dysfunction of the blood coagulation-fibrinolysis system is a salient characteristic of VTE requiring optimized management depending on its severity. Therefore, finding suitable biomarkers that could predict the onset of VTE could be helpful. DISCLOSURES: No relevant relationships by aamer Chughtai, source=Web Response no disclosure on file for XIAO GAN; No relevant relationships by Lu Guo, source=Web Response no disclosure on file for YICEN HAN; no disclosure on file for Yanxin Li; no disclosure on file for Jingyan Liu; no disclosure on file for jing zhang; no disclosure on file for Jing Zhang; no disclosure on file for Taiqiang Zhao

TGFβ1 plasma levels and clot lysis assay to better characterize patients after a first unprovoked episode of pulmonary embolism

Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment

Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial

Decreased Thrombin Generation is Associated with Increased Thrombin Generation Biomarkers and Blood Cellular Indices in Pulmonary Embolism

Fibrinogen levels and clot properties identify patients that benefit from catheter-directed thrombolysis after DVT

Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: A systematic review and meta-analysis

Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B

Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial

Protracted fibrinolysis resistance following cardiac surgery with cardiopulmonary bypass: A prospective observational study of clinical associations and patient outcomes

36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

Fibrinolysis is impaired in patients with primary immune thrombocytopenia

Impact of reperfusion therapies on clot resolution and long-term outcomes in patients with pulmonary embolism

ASSOCIATION OF IMPACT FACTORS AND PREDICTIVE BIOMARKERS WITH HIGH RISK OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED PATIENTS WITH ACUTE EXACERBATION OF COPD

Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

Add-on GLP-1 agonists in the treatment of intermediate risk acute pulmonary embolism: a biomarker-driven proof-of-concept study

Predictors of pulmonary embolism in chronic obstructive pulmonary diseases patients admitted for worsening respiratory symptoms: An individual participant data meta-analyses

Endothelial Overexpression of TGF-β-Induced Protein Impairs Venous Thrombus Resolution: Possible Role in CTEPH

Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes

The Relationship Between D-Dimer Level, Venous Valvular Reflux and Development of the Post-Thrombotic Syndrome after Deep Venous Thrombosis.

Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis